In the BioHarmony Drug Report Database

"Preview" Icon

Ecallantide

Kalbitor (ecallantide) is a protein pharmaceutical. Ecallantide was first approved as Kalbitor on 2009-12-01. It is used to treat hereditary angioedemas in the USA.

 

Trade Name

 

Kalbitor
 

Common Name

 

ecallantide
 

ChEMBL ID

 

CHEMBL1201837
 

Indication

 

hereditary angioedemas
 

Drug Class

 

Peptides

Image (chem structure or protein)

Ecallantide structure rendering